The market for microencapsulation is anticipated to be worth US$ 6.5 billion in 2022 and grow to US$ 10.3 billion by 2032 at a CAGR of 8.2%.
As the need for functionally enhanced foods and drugs develops, microencapsulation is becoming increasingly popular. Microencapsulated flavours, vitamins, minerals, essential oils, and other additives can be added to foods to improve their nutritional value.
Due to the benefits achieved by producers, microencapsulation technologies have a considerable impact on the pharmaceutical business. To satisfy consumer demand for value-added products, active substances like biomolecules, proteins, and genetic molecules are packaged in the pharmaceutical industry.
Unlock Growth Potential in Your Industry – Get Your Sample Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-11258
Major corporations all over the world are concentrating on encapsulation because they see it as an immune-protection strategy. The microencapsulation industry makes and sells its products globally using a lot of technology.
Textiles will eventually become a popular segment of the global microencapsulation market. Rising demand for cosmo-textile production technologies should assist market expansion. Personal care product consumption is expected to rise due to changing lifestyles, which could bode well for the microencapsulation business.
Key Takeaways from Market Study
- North America represented 33% of overall sales in North America in 2021, because of the strong demand for pharmaceutical-grade food and beverages.
- The UK Microencapsulation Market is expected to grow at a CAGR of 5.9% from 2022 to 2032, owing to the early adoption of the technology in end-use applications. Large pharmaceutical corporations in the region, such as GlaxoSmithKline and Novartis, have influenced market demand by concentrating on the development of new drug delivery techniques.
- In terms of applicability, the pharmaceutical and healthcare products industry is anticipated to be the most profitable. For regulated medicine delivery, microencapsulation is commonly employed in the healthcare and pharmaceutical industries. Pharmaceutical companies routinely use microencapsulation technology to hide the strong taste or odor of medications and to allow for targeted and controlled delivery.
- Gelatine is a widely used coating material that is predicted to expand at a substantial rate of more than 5% CAGR throughout the forecast period. Because it is a water-soluble resin, it is frequently employed in the pharmaceutical, food, and agriculture industries.
Embrace Smarter Choices With Our Methodology-Derived Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-11258
Who is Winning?
Microencapsulation’s growth is expected to be fueled by its growing popularity in a range of end-user industries. Because qualities including durability, bioavailability, distribution, and efficacy are all closely regulated, encapsulation is essential for medicinal foods, nutraceuticals, and meal-replacement products.
For example, In India, Koninklijke DSM opened a second plant for animal nutrition and health premixes in 2018. The firm has grown its geographical presence as well as its manufacturing capability as a result of this expansion, in order to meet the region’s expanding demand.
Some of the leading companies offering microencapsulation are Reed Pacific, Novartis, Encapsys, GAT Microencapsulation, Koninklijke DSM, GlaxoSmithKline, Ronald T. Dodge Company, Capsulae, and AVEKA.
Get More Valuable Insights
Future Market Insights, in its new offering, provides an unbiased analysis of the microencapsulation market presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.
The study divulges compelling insights on microencapsulation based on application (pharmaceutical & healthcare products, food & beverages, household & personal care products, agrochemicals, construction material, textiles, and other applications), technology (spray technology, dripping technology, emulsion technology, and other technologies), core material (agricultural inputs, food additives, pharmaceutical & healthcare drugs, fragrances, phase change material, other core materials), shell material (polymers, gums & resins, lipids, carbohydrates, proteins) across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).
Gain Immediate Access to Detailed Market Insights Purchase Now: https://www.futuremarketinsights.com/checkout/11258
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube